H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure. Census population 189,692. Rhode Island Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Providence clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Providence storefront.
Chronic Wound Treatment That Works in Providence, RI for clinics & physicians. Effective chronic wound tre… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of chronic wound treatment in Providence: (1) CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure. (2) Rhode Island Part B wound biologics are reviewed by National Government Services (NGS) under JK, shared with CT, MA, ME, NH, NY, VT. We help with the second file. We do not pretend to be a Providence storefront.
National Chronic Wound Treatment That Works notes (how the product actually works)Three grains, kept separate on purpose. City: Census 189,692 and CDC PLACES crude rates. State: Rhode Island Department of Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and National Government Services (NGS) LCDs. CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure. Adult arthritis here is 18.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Providence.
CDC PLACES (2023, crude prevalence) estimates 11.5% of adults — 0.5 points below the U.S. 12% figure. Obesity is 34.4%; arthritis is 18.8%. That is place-level BRFSS modeling, not a clinic census and not a Providence trial.
Regulatory lane, storage, and JK coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Rhode Island. There is no Providence storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Providence, RI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Providence is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Providence — 0.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Rhode Island Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, NY, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Providence. Useful for joint-program math; still needs a diagnosis and privileging.
No Providence storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.